Principles and uses of academic detailing to improve the management of psychiatric disorders

International Journal of Psychiatry in Medicine

Volumn 28, Issue 1, 1998, Pages 81-96

  Soumerai, Stephen B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Academic detailing; Educational outreach; Mental health care; Primary care; Quality assurance

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DEXTROPROPOXYPHENE; DIPHENHYDRAMINE; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; MEDICAL EDUCATION; MENTAL HEALTH CARE; PERFORMANCE; PRIMARY MEDICAL CARE; PSYCHIATRIC DIAGNOSIS; QUALITY CONTROL; REINFORCEMENT;

EID: 0031781022     PISSN: 00912174     EISSN: None     Source Type: Journal    
DOI: 10.2190/BTCA-Q06P-MGCQ-R0L5     Document Type: Conference Paper

References (36)

1. Davis DA, Thomson MS, Oxman AD, Haynes RB. Changing physician performance: A systematic review of the effect of continuing medical education strategies. Journal of the American Medical Association 1995;274:700-705.
2. Soumerai SB, Lipton HL. Evaluating and improving physician prescribing. In: Strom BL, editor. Pharmacoepidemiology. 2nd ed. Chicester, UK: John Wiley, 1994: 395-412.
3. Greco PJ, Eisenberg JM. Changing physicians' practices. New England Journal of Medicine 1993;329:1271-1274.
4. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. New England Journal of Medicine 1994;331:650-655.
5. Eisenberg JM. Doctors' decisions and the costs of medical care. Ann Arbor, MI: Health Administration Press, 1986.
6. McDonald CJ. Protocol-based computer reminders, the quality of care and the nonperfectibility of man. New England Journal of Medicine 1976;295:; 1351-1355.
7. Barnett GO, Winikoff RN, Dorsey JL, Morgan MM, Lurie RS. Quality assurance through automated monitoring and concurrent feedback using a computer-based medical information system. Medical Care 1978; 16:962-970.
8. Soumerai SB, Avorn J, Gortmaker S, Hawley S. Effect of government and commercial warnings on reducing prescription misuse: The case of propoxyphene. American Journal of Public Health 1987;77:1518-1523.
9. Soumerai SB, Avorn J. Predictors of physician prescribing change in an educational experiment to improve medication use. Medical Care 1987;25:210-221.
10. Soumerai SB, Avorn J. Economic and policy analysis of university based drug "detailing." Medical Care 1986;24:313-331.
11. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach: a randomized controlled trial of academically based "detailing." New England Journal of Medicine 1983;308:1457-1463.
12. Soumerai SB, Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. Journal of the American Medical Association 1990;263:549-556.
13. Schaffner W, Ray WA, Federspiel CF, Miller WO. Improving antibiotic prescribing in office practice: A controlled trial of three educational methods. Journal of the American Medical Association 1983;250:1728-1732.
14. Ray WA, Schaffner W, Federspiel CF. Persistence of improvement in antibiotic prescribing in office practice. Journal of the American Medical Association 1985; 253:1774-1776.
15. Diwan VK, Wahlstrom R, Tomson G, Beermann B, Sterky G, Eriksson B. Effects of 'group detailing' on the prescribing of lipid-lowering drugs: A randomized controlled trial in Swedish primary care. Journal of Clinical Epidemiology 1995;48: 705-711.
16. Treloar C, Higginbotham N, Malcolm J, Sutherland D, Berenger S. An "academic detailing" intervention to decrease exposure to HIV infection among health care workers. Journal of Health Psychology 1996;1(4):455-468.
17. Ross-Degnan D, Soumerai SB, Goel PK, Bates J, Makhulo J, Dondi N, Sutoto, Adi D, Ferraz-Tabor L, Hogan R. The impact of face-to-face educational outreach on diarrhea treatment in pharmacies. Health Policy and Planning 1996;11:308-318.
18. Soumerai SB, Salem-Schatz S, Avorn J, Casteris CS, Ross-Degnan D, Popovsky MA. A controlled trial of educational outreach to improve blood transfusion practice. Journal of the American Medical Association 1993;270:961-966.
19. Rabin DL, Boekleoo BO, Marx ES, Bowman MA, Russell NK, Gonzalez WA. Improving office-based physicians' prevention practices for sexually transmitted diseases. Annals of Internal Medicine 1994;121:513-519.
20. Dietrich AJ, O'Connor GT, Keller A, Carney PA, Levy D, Whaley FS. Cancer Improving early detection and prevention. A community practice randomised trial. British Medical Journal 1992;304:687-691.
21. Cockburn J, Ruth D, Silagy C, Dobbin M, Reid Y, Scollo M, Naccarella L. Randomised trial of three approaches for marketing smoking cessation programmes to Australia general practitioners. British Medical Journal 1992;304: 691-694.
22. Putnam RW, Curry L. Impact of patient care appraisal on physician behavior in the office setting. Canadian Medical Association Journal 1985;132:1025-1029.
23. Schwartz RK, Soumerai SB, Avorn J. Physician motivations for nonscientific drug prescribing. Social Science and Medicine 1989;28:577-582.
24. Skinner BF. The behavior of organisms. New York: Appleton-Century, 1938.
25. Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education: Theory, research and practice. San Francisco, CA: Jossey-Bass, Inc., 1990.
26. Thomson MA, Oxman AD, Haynes RB, Davis DA, Freemantle N, Hawley EL. Outreach visits to improve health professional practice and health care outcomes. Cochrane Collaboration on Effective Professional Practice. University of York, Heslington, York YO1 5DD, UK.
27. Ray WA, Blazer DG, Schaffner W, Federspiel CF. Reducing antipsychotic drug prescribing for nursing home patients: A controlled trial of the effect of an educational visit. American Journal of Public Health 1987;77:1448-1450.
28. Ray WA, Blazer DG, Schaffner W, Federspiel CF, Fink R. Reducing long-term diazepam prescribing in office practice: A controlled trial of educational visits. Journal of the American Medical Association 1986;256:2536-2539.
29. Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, Salem-Schatz SR, Fields D. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. New England Journal of Medicine 1992; 327:168-173.
30. Ray WA, Griffith MR, Schaffner W, Baugh DK, Melton LJ III. Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine 1987;316: 363-369.
31. Ray WA, Griffith MR, Downey W. Benzodiazepines of long and short elimination half life and the risk of hip fracture. Journal of the American Medical Association 1989;262:3303-3307.
32. Ray WA, Taylor JA, Meador KG, Lichtenstein MJ, Griffin MR, Fought R, Adams ML, Blazer DG. Reducing antipsychotic drug use in nursing homes: A controlled trial of provider education. Archives of Internal Medicine 1993;153:713-721.
33. Soumerai SB, Ross-Degnan D, Fortess EE, Abelson J. A critical analysis of studies of state drug reimbursement policies: Research in need of discipline. Milbank Quarterly 1993;71:217-252.
34. Fifer SK, Mathias SD, Patrick DL. Untreated anxiety among adult primary care patients in a health maintenance organization. Archives of General Psychiatry 1994; 51:740-750.
35. Lin E, VonKorff M, Katon W, Bush T, Simon GE, Walker E, Robinson P. The role of the primary care physician in patients' adherence to antidepressant therapy. Medical Care 1995;33:67-74.
36. Kane JM, Marder SR. Psychopharmacologic treatment of schizophrenia. Schizophrenia Bulletin 1993;19:287-302.